Cargando…
Toxicogenomics profiling of bone marrow from rats treated with topotecan in combination with oxaliplatin: a mechanistic strategy to inform combination toxicity
Combinations of anticancer agents may have synergistic anti-tumor effects, but enhanced hematological toxicity often limit their clinical use. We examined whether “microarray profiles” could be used to compare early molecular responses following a single dose of agents administered individually with...
Autores principales: | Davis, Myrtle, Li, Jianying, Knight, Elaine, Eldridge, Sandy R., Daniels, Kellye K., Bushel, Pierre R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325931/ https://www.ncbi.nlm.nih.gov/pubmed/25729387 http://dx.doi.org/10.3389/fgene.2015.00014 |
Ejemplares similares
-
Transcriptomic profiles of tissues from rats treated with anticancer drug combinations
por: Davis, Myrtle, et al.
Publicado: (2019) -
The Impact of Classification of Interest on Predictive Toxicogenomics
por: Kerns, Robnet T., et al.
Publicado: (2012) -
Database development in toxicogenomics: issues and efforts.
por: Mattes, William B, et al.
Publicado: (2004) -
Editorial: Integrative Toxicogenomics: Analytical Strategies to Amalgamate Exposure Effects With Genomic Sciences
por: Bushel, Pierre R., et al.
Publicado: (2018) -
Proceedings of the First International Conference on Toxicogenomics Integrated with Environmental Sciences (TIES-2007)
por: Bushel, Pierre R, et al.
Publicado: (2009)